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Weight Loss in Obese Pregnant Women and
Risk for Adverse Perinatal Outcomes
Annick Bogaerts, PhD, Lieveke Ameye, PhD, Evelyne Martens, MSc, and Roland Devlieger, PhD
OBJECTIVE: To examine the association between weight
loss in obese pregnant women and relevant maternal and
neonatal outcomes.
METHODS: All liveborn singleton term (37 weeks of
gestation or greater) births in obese women between
2009 and 2011 in Flanders (the northern part of Belgium)
were included (N518,053). Outcomes assessed included
gestational hypertension, low (2,500 g or less) birth
weight, small-for-gestational-age (less than the 10th per-
centile) neonates, macrosomia (birth weight 4,000 g or
greater), large-for-gestational-age (greater than 90th
percentile) neonates, emergency caesarean delivery,
and admission to a neonatal intensive care unit. Risk
for adverse outcomes was calculated by multiple logistic
regression analysis for weight change categories (greater
weight loss [5 kg or greater], lesser weight loss [between
0 and 5 kg], low gestational weight gain [0 or greater and
less than 5 kg], adequate gestational weight gain [5 or
greater to 9 kg or less, reference], and excessive gesta-
tional weight gain [greater than 9 kg]) in each obesity
class (I 30–34.9, II 35–39.9, III 40 or greater) adjusted
for parity and maternal and gestational age.
RESULTS: In the total population, 854 (4.7%) obese
pregnant women reported weight loss. Weight loss and
low weight gain were associated with a decreased
incidence of gestational hypertension for women with
class I obesity (greater weight loss adjusted odds ratio
[OR] 0.31, 95% confidence interval [CI] 0.11–0.84;
lesser weight loss adjusted OR 0.46 95% CI 0.21–0.99;
low gain adjusted OR 0.71 95% CI 0.54–0.93), a reduc-
tion in the rate of emergency cesarean delivery, but
only in those with class II obesity (greater weight loss
adjusted OR 0.24, 95% CI 0.07–0.78; lesser weight loss
adjusted OR 0.50, 95% CI 0.26–0.97; low gain adjusted
OR 0.55, 95% CI 0.38–0.79), and decreased macroso-
mia and large-for-gestational-age neonates in women
in all classes of obesity, with the highest decrease for
women with class III obesity (greater weight loss
adjusted OR 0.15, 95% CI 0.05–0.49; lesser weight loss
adjusted OR 0.37, 95% CI 0.15–0.90 for macrosomia).
No association between weight loss and low birth
weight, small-for-gestational-age neonates, or admis-
sion to the neonatal intensive care unit was shown in
the different obesity classes.
CONCLUSION: Weight loss in obese pregnant women
was associated with reduced perinatal risks but not
with the rate of low birth weight or small-for-
gestational-age neonates in obese women from class
III in this affluent region. Stratification of recommen-
ded gestational weight gain ranges in obese women
should be considered.
(Obstet Gynecol 2015;125:566–75)
DOI: 10.1097/AOG.0000000000000677
LEVEL OF EVIDENCE: II
Obesity during pregnancy (body mass index[BMI, calculated as weight (kg)/[height (m)]2]
30 or greater) is a major public health concern
because of the increased risks for both the mother
and child. Obesity-associated risks include spontane-
ous abortion1 and congenital malformations,2 meta-
bolic and cardiovascular dysfunctions presented as
gestational diabetes3 and hypertension,4 and cesarean
From the UC Leuven-Limburg, Department of Healthcare Limburg, Hasselt,
CRIC, Center for Research and Innovation in Care, Department of Nursing and
Midwifery Sciences, University of Antwerp, Antwerp, the Department of
Development and Regeneration, KU Leuven, and the Department of Obstetrics
& Gynaecology, Division of Mother & Child, University Hospitals, Leuven, and
the Flemish Study Centre for Perinatal Epidemiology (SPE), Brussels, Belgium.
The Study Centre for Perinatal Epidemiology (SPE) is financed and commissioned
by the Flemish Centre for Care and Health (Agentschap Zorg en Gezondheid).
Roland Devlieger is senior clinical researcher for FWO Flanders (2010–2015).
Presented in part at the 61st Annual Meeting of the Society for Gynecologic
Investigation, March 26–29, 2014, Florence, Italy.
The authors thank the Flemish Study Center for Perinatal Epidemiology (SPE)
for their contribution in providing all the data and Marianne Mead for her
review of the paper and her linguistic advice.
Corresponding author: Roland Devlieger, PhD, Department of Obstetrics and
Gynaecology, University Hospitals Leuven, Herestraat, 49, 3000 Leuven,
Belgium; e-mail: roland.devlieger@uzleuven.be.
Financial Disclosure
The authors did not report any potential conflicts of interest.
© 2015 by The American College of Obstetricians and Gynecologists. Published
by Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0029-7844/15
566 VOL. 125, NO. 3, MARCH 2015 OBSTETRICS & GYNECOLOGY
Copyright ª by The American College of Obstetricians
and Gynecologists. Published by Wolters Kluwer Health, Inc.
Unauthorized reproduction of this article is prohibited.
delivery.5,6 For the neonate, there is an increased risk
of macrosomia and admission to a neonatal care
unit.7,8 In the long term, children of obese mothers
who were prone to metabolic dysfunctions in utero
(fetal programming) may face further metabolic and
cardiovascular problems as well as neurocognitive
developmental problems.9,10
The Institute of Medicine (IOM) revised the
gestational weight gain guidelines in 2009 and rec-
ommended that obese women should gain between 5
and 9 kg to obtain the best maternal and perinatal
outcomes.11 Emerging evidence suggests, however,
that these recommendations are still too high and that
even weight loss in pregnancy may have substantial
benefits for both mother and child. Perinatal risks
increase with increasing prepregnancy BMI and
because we intended to examine the women with
the highest risk in greater depth, we decided to study
only obese pregnant women. We therefore examined
the association between weight loss in obese women
and risk for gestational hypertension, low (less than
2,500 g) birth weight and small-for-gestational-age
(SGA) neonates, macrosomia (birth weight 4,000 g
or greater) and large-for-gestational-age (LGA) neo-
nates, emergency caesarean delivery, and admission
to a neonatal intensive care unit (NICU).
MATERIALS AND METHODS
The Flemish Study Center for Perinatal Epidemiology
has routinely registered perinatal data from all deliv-
eries in Flanders since 1996. Perinatal data from all
maternity units (n565) are collated centrally, sub-
jected to an error detection program, and checked
for accuracy and completeness through feedback with
the individual maternity units and reassessment of
patient records when required. In case of extreme
values (considered outliers) or missing values, the
maternity units are contacted for confirmation or cor-
rection.12 All stillbirths or live births of neonates with
a weight of 500 g or greater are included; the defini-
tions used are in agreement with those from the
World Health Organization and the Fédération Inter-
nationale de Gynécologie et d’Obstétrique. The Flem-
ish Study Center for Perinatal Epidemiology database
contains data about maternal and gestational age
(completed weeks) at delivery, parity, gestational
hypertension, gestational diabetes, mode of delivery,
birth weight, sex, congenital malformations, admis-
sion to a NICU, and perinatal mortality and, from
2009, self-reported maternal height and weight before
pregnancy and weight measured at delivery or at the
last antenatal visit.13
Data, including BMI and gestational weight gain,
were available for 18,065 obese pregnant women who
delivered singleton term live births between 2009 and
2011; 12 participants were excluded because of unreli-
able information on gestational weight change (weight
loss more than 45 kg and gains of more than 60 kg).
Ranges of maternal height (1.26–1.93 m), prepregnancy
weight (53–170 kg), and weight at delivery (40–187 kg)
were deemed acceptable. A total of 18,053 obese
women were therefore included in the analysis.
The scientific committee of the Flemish Study
Center for Perinatal Epidemiology granted approval
for the analysis of the anonymized data. This study was
exempt from approval by an institutional review board.
Body mass index was categorized according to
the World Health Organization and the IOM-
matched cutoffs.11,14 Obesity was defined as a BMI
of 30 or greater and further categorized as obesity
class I (BMI 30–34.9), class II (BMI 35–39.9), and
class III (BMI 40 or greater). Gestational weight
change was calculated by subtracting the maternal
prepregnancy weight from the weight at delivery
and was categorized as greater weight loss (5 kg or
greater), lesser weight loss (between 0 and 5 kg), low
gestational weight gain (0 or greater and less than
5 kg), normal gestational weight gain (5 or greater to
9 kg or less, in accordance with the 2009 IOM guide-
lines for obese women), and excessive gestational
weight gain (greater than 9 kg). Similar weight change
categories were used in other studies.15,16 Prepreg-
nancy weight and height were self-reported during
pregnancy. Maternal weight at delivery was measured
in the delivery room or, if not available, the weight at
the last prenatal visit was used.
We considered eight main outcomes of interest:
gestational diabetes and gestational hypertension,
emergency cesarean delivery, macrosomia (birth
weight 4,000 g or greater), LGA (greater than 90th
percentile), low birth weight (less than 2,500 g) SGA
(less than the 10th percentile), and admission to
a NICU. Small- and LGA neonates were defined by
birth weights less than the 10th percentile or greater
than 90th percentile, respectively, according to gesta-
tional age, sex, and parity-specific reference percen-
tiles from our regional birth weight charts (Flemish
Study Center for Perinatal Epidemiology, 2009). All
of these outcomes were retrieved from the Study
Center for Perinatal Epidemiology database.
In univariate analysis to assess the relation
between the eight outcomes and categorical variables,
likelihood ratio x2 and Maentel-Haenszel x2 were
used. To assess the relation with continuous variables,
t test and Mann-Whitney test were used. For the
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Table 1. Univariate Associations Between Maternal and Neonatal Outcomes and Classes of Obesity,
Weight Change Categories, and Maternal Characteristics (N518,053)
Maternal
Characteristics
Gestational
Hypertension
(n51,923)
Gestational
Diabetes
(n51,109)
Macrosomia
(4,000 g or
Greater)
(n52,882)
LGA
(Greater
Than the
90th
Percentile)
(n53,124)
Low
Birth
Weight
(2,500 g
or Less)
(n5258)
SGA (Less
Than the
10th
Percentile)
(n51,288)
Emergency
Caesarean
Delivery
(n52,182)
Admission
to NICU
(n5351)
Obesity class
(BMI
[kg/m2])
I (30–34.9) 9.02 5.23 15.41 16.34 1.39 7.33 11.36 1.82
II (35–39.9) 13.36 7.71 16.64 18.59 1.51 6.89 13.12 2.09
III (40 or
greater)
19.26 10.85 19.58 23.35 1.57 5.82 16.43 2.75
P ,.001 ,.001 ,.001 ,.001 .51 .04 ,.001 .02
Weight change
category
(kg)
Greater
weight
loss (5 or
more)
6.82 11.02 5.25 7.87 2.10 12.34 8.92 0.79
Lesser
weight
loss (0–5)
8.25 11.42 9.09 9.73 1.90 11.21 9.73 2.54
Low weight
gain (0 to
less than
5)
8.78 8.50 11.23 11.59 2.01 9.39 9.31 1.44
Adequate
weight
gain
(5–9)
9.12 6.97 13.46 14.84 1.52 8.16 10.57 2.09
Excessive
weight
gain
(more
than 9)
12.23 4.63 19.30 20.85 1.18 5.59 13.86 2.01
P ,.001 ,.001 ,.001 ,.001 ,.001 ,.001 ,.001 .13
Maternal age (y)
Younger
than 20
7.32 2.93 9.27 12.68 2.93 7.80 16.10 2.44
20–24.99 9.43 4.30 12.52 14.48 1.49 8.57 13.73 2.15
25–29.99 11.03 4.52 15.84 17.39 1.18 6.22 12.41 1.67
30–34.99 10.37 6.45 16.65 17.74 1.38 6.96 10.87 1.98
34–39.99 11.01 9.87 18.35 19.18 1.78 8.21 11.56 1.85
40 or older 14.09 14.61 17.91 18.09 2.43 8.00 13.74 4.00
P .01 ,.001 ,.001 ,.001 .05 .58 .001 .02
Gestational
age (wk)
37 16.56 12.82 6.72 22.18 5.96 6.51 13.51 4.44
38 13.38 10.42 9.07 17.41 2.23 6.39 10.06 2.47
39 10.64 5.41 13.17 16.61 0.91 6.74 9.43 1.53
40 8.75 3.71 20.72 17.37 0.66 7.77 12.16 1.51
41 7.09 2.24 27.12 15.56 0.25 8.18 19.49 1.43
42 6.90 3.45 33.62 15.52 0.00 6.03 20.69 1.72
(continued )
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multivariate analyses, we only considered seven of the
eight outcomes as we excluded patients with gesta-
tional diabetes (n51,109) as a result of the possible
bias of diet interventions subsequent to the diagnosis
of gestational diabetes in midpregnancy and the sub-
sequent effect on the mother’s weight change. More-
over, we did not have information about the weight
gain at the time of diabetes diagnosis. For each of the
seven outcomes, we built a logistic regression model
to assess the association of gestational weight change
with the outcome adjusting for parity, maternal age,
and gestational age. The logistic regression models
were performed twice: once with gestational weight
change as a categorical variable and once as a contin-
uous variable. For multiparous women with maternal
age of 30 years and gestational age of 39 weeks, we
calculated the predicted probability on an adverse
outcome for each possible value of gestational weight
change. Those predicted probabilities are presented
graphically.
To adjust for multiple hypothesis testing, we
applied the Bonferroni correction for the eight
outcomes of interest, and we took into account the
five categories of gestational weight gain (four
comparisons); the statistical significance level be-
comes .05/(834)5.002.
All statistical analyses were performed with
SAS 9.4.
RESULTS
In this cohort of obese pregnant women, 854 (4.7%)
reported weight loss, 2,493 (13.8%) had a low weight
gain (0–5 kg), 5,120 (28.3%) had an adequate gesta-
tional weight gain (5–9 kg), and 9,586 (53.1%) had
gestational weight gain greater than 9 kg (excessive
according to 2009 IOM guidelines). Within the obesity
classes, 3.2% from class I lost weight during pregnancy
compared with 7% from class II and 13.4% from class
III. Increasing classes of obesity were associated with
higher parity (P5.003) and lower gestational age at
delivery (P,.001), whereas there was no difference
in maternal age among the three classes (P5.31).
The prevalence of adverse perinatal outcomes
significantly increased by increasing class of obesity,
except for low birth weight (P5.51). The prevalence
of SGA neonates decreased by increasing class of
obesity (P5.04). In the univariate analysis, gestational
hypertension, macrosomia, LGA neonates and emer-
gency caesarean delivery decreased with decreasing
categories of weight gain. The prevalence of gesta-
tional diabetes, low birth weight, and SGA neonates
decreased with increasing categories of weight gain,
whereas there was no difference for admission to
a NICU (Table 1). In the total sample, 45.6%
(n58,242) of obese women had at least one of the
perinatal complications of interest. Of the 1,109 obese
women who were excluded for gestational diabetes in
the multivariate analysis, 47.3% (n5524) had gesta-
tional diabetes only, 19.2% (n5213) gestational diabe-
tes and macrosomia or LGA neonates, and 9.2%
(n5100) gestational diabetes and hypertension.
In the adjusted multivariate analysis, weight loss
and low gestational weight gain were associated with
a decreased adjusted odds ratio (OR) of gestational
hypertension for women with class I obesity (greater
weight loss adjusted OR 0.31, 95% confidence interval
[CI] 0.11–0.84; lesser weight loss adjusted OR 0.46
95% CI 0.21–0.99; low gain adjusted OR 0.71 95%
CI 0.54–0.93). Weight loss and low gain were also
associated with a decreased adjusted OR of emer-
gency caesarean deliveries, but only for women from
class II (greater weight loss adjusted OR 0.24, 95% CI
Table 1. Univariate Associations Between Maternal and Neonatal Outcomes and Classes of Obesity,
Weight Change Categories, and Maternal Characteristics (N518,053) (continued )
Maternal
Characteristics
Gestational
Hypertension
(n51,923)
Gestational
Diabetes
(n51,109)
Macrosomia
(4,000 g or
Greater)
(n52,882)
LGA
(Greater
Than the
90th
Percentile)
(n53,124)
Low
Birth
Weight
(2,500 g
or Less)
(n5258)
SGA (Less
Than the
10th
Percentile)
(n51,288)
Emergency
Caesarean
Delivery
(n52,182)
Admission
to NICU
(n5351)
P ,.001 ,.001 ,.001 ,.001 ,.001 .002 ,.001 ,.001
Parity
Primiparous 15.45 6.14 12.88 17.61 2.04 7.68 22.24 2.17
Multiparous 7.80 6.15 17.80 17.13 1.07 6.81 6.05 1.81
P ,.001 .98 ,.001 .41 ,.001 .03 ,.001 .09
LGA, large for gestational age; SGA, small for gestational age; NICU, neonatal intensive care unit; BMI, body mass index.
Data are % by row unless otherwise specified.
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0.07–0.78; lesser weight loss adjusted OR 0.50, 95%
CI 0.26–0.97; low gain adjusted OR 0.55, 95% CI
0.38–0.79). For neonatal outcomes, weight loss was
associated with decreased macrosomia and LGA neo-
nates in all classes of obesity, with the highest effect in
women with class III obesity (greater weight loss
adjusted OR 0.15, 95% CI 0.05–0.49; lesser weight
loss adjusted OR 0.37, 95% CI 0.15–0.90 for macro-
somia). Concurrently, no association was shown
between weight loss and low birth weight, SGA neo-
nates or admission to a NICU in the different classes
of obesity (Table 2).
In the multivariate analysis with weight change
during pregnancy as a continuous variable, gestational
weight gain was inversely related to low birth weight
only for class I obese women (adjusted OR 0.97, 95%
CI 0.95–0.99) and inversely related to SGA neonates
for class I (adjusted OR 0.96, 95% CI 0.95–0.97) and
class II (adjusted OR 0.97, 95% CI 0.95–0.98) obese
women. Figure 1 shows the predicted probability of
all the seven complications of interest, related to ges-
tational weight gain, by class of obesity. The highest
predicted probabilities are shown for macrosomia
and LGA neonates. Figure 1 demonstrates that the
predicted probabilities of macrosomia and LGA neo-
nates are closely related in class I and II of obesity; in
class III, the intercept of macrosomia is lower than for
LGA neonates.
As shown in Figure 2, the lowest predicted prob-
ability for SGA and LGA combined was associated
with a weight gain of 0–5 kg in class I obesity,
0–5 kg weight loss in class II, and up to 15 kg weight
loss in class III (additional material can be found as
Appendix 1, available online at http://links.lww.com/
AOG/A606).
DISCUSSION
In this observational study, obese pregnant women
who have a weight gain lower than recommended by
the 2009 IOM guidelines have reduced risks of
gestational hypertension, emergency caesarean deliv-
ery, macrosomia, and LGA neonates. Furthermore,
those who lost weight (which was apparent in 5% of
obese women) had a lower risk for gestational hyper-
tension, emergency cesarean delivery, macrosomia,
and LGA neonates, and this was not at the expense of
an increase in low birth weight or SGA neonates.
Most studies cautiously recommend lower weight
gains, no weight gain, or even weight loss for obese
pregnant women to prevent adverse maternal out-
comes.6,16–18 On the other hand, studies have until
now demonstrated a positive association between
Table 2. Adjusted Odds Ratios for Maternal and Neonatal Outcomes in Relation to Weight Change
Categories (n516,944)
Weight Change Category (kg)
Gestational Hypertension
(n51,740)
Emergency Caesarean Delivery
(n52,009)
Macrosomia
(n52,677)
Class I obesity
Greater weight loss (5 or more) 0.31 (0.11–0.84) 1.06 (0.62–1.79) 0.47 (0.24–0.90)
Lesser weight loss (0 –5) 0.46 (0.21–0.99) 0.78 (0.45–1.35) 0.62 (0.37–1.05)
Low gain (0 to less than 5) 0.71 (0.54–0.93) 1.01 (0.80–1.26) 0.79 (0.64–0.97)
Adequate gain ([ref] 5–9) 1.00 1.00 1.00
Excessive gain (more than 9) 1.49 (1.28–1.74) 1.22 (1.06–1.40) 1.73 (1.53–1.96)
Class II obesity
Greater weight loss (5 or more) 0.55 (0.23–1.30) 0.24 (0.07–0.78) 0.32 (0.12–0.90)
Lesser weight loss (0–5) 0.80 (0.44–1.44) 0.50 (0.26–0.97) 0.79 (0.45–1.39)
Low gain (0 to less than 5) 0.95 (0.69–1.32) 0.55 (0.38–0.79) 0.87 (0.64–1.19)
Adequate gain ([ref] 5–9) 1.00 1.00 1.00
Excessive gain (more than 9) 1.33 (1.05–1.69) 1.02 (0.81–1.29) 1.73 (1.39–2.15)
Class III obesity
Greater weight loss (5 or more) 0.57 (0.26–1.27) 0.78 (0.36–1.68) 0.15 (0.05–0.49)
Lesser weight loss (0 –5) 1.27 (0.63–2.55) 1.71 (0.82–3.55) 0.37 (0.15–0.90)
Low gain (0 to less than 5) 1.22 (0.80–1.88) 1.05 (0.64–1.71) 0.67 (0.43–1.02)
Adequate gain ([ref] 5–9) 1.00 1.00 1.00
Excessive gain (more than 9) 1.39 (0.95–2.03) 1.09 (0.72–1.65) 1.08 (0.75–1.54)
LGA, large for gestational age; SGA, small for gestational age; NICU, neonatal intensive care unit; ref, reference.
Data are adjusted odds ratio (95% confidence interval).
Bold indicates Institute of Medicine–inadequate gestational weight gain and P ,.05.
Bold and italics indicates Institute of Medicine–inadequate gestational weight gain and P ,.002 (Bonferroni-corrected).
* LGA and SGA are adjusted for maternal age and parity.
† Weight loss categories were combined as a result of small number adjusted for parity, maternal, and gestational age.
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weight loss and SGA neonates.15,16,19,20 The results of
our study differ from the retrospective analysis of Cat-
alano et al.19 They included 1,241 singleton term
overweight and obese pregnancies from two ongoing
trials and concluded that weight loss or gain 5 kg or
less was associated with more SGA neonates, lower
birth weight, and lower fat and lean mass of the neo-
nate compared with women with more than 5-kg
weight gain. In their analysis, overweight and obese
women were combined and only 46 of them had re-
ported a weight loss. The mean weight gain in their
weight loss and gain category was 1.1 kg (standard
deviation [SD] 4.4) compared with 14.4 kg (SD 6.2)
in their greater than 5-kg weight gain category. In our
analysis, we included only obese women (n518,053)
and reported a weight loss in 854 women. The mean
weight loss (n5854) in our analysis was 5.96 kg (SD
5.99); mean weight gain (n517,199) was 10.76 kg (SD
6.06). Although Catalano et al19 aimed to evaluate the
association of inadequate gestational weight gain and
fetal growth, they included overweight as well as
extreme obese pregnant women, but these two groups
may have different metabolic rates, which could affect
the neonatal outcomes.
Previously, SGA has been associated with weight
loss in women with class I and II but not class III
obesity.20,21 Hinkle et al21 showed that in class II and
III women, a gestational weight gain from 24.9 kg
to +4.9 kg (compared with those with gestational
weight gain between 5 and 9 kg) did not significantly
increase the odds of SGA and had the benefit of reduc-
ing macrosomia. Oza-Frank22 showed an 11% increase
in SGA for each kilogram of weight loss in obese
women, but only in those from class I; no difference
in SGA was demonstrated in obese women from clas-
ses II and III. When they compared obese women with
weight gain less than 5 kg with those with adequate
gestational weight gain (5–9 kg), no association with
SGA was found between the obesity classes. Li et al23
also demonstrated no difference in adjusted ORs for
SGA and low birth weight if obese women had a weight
gain less than 5 kg. These results match ours.
Thus, it appears that an increasing maternal BMI
mitigates the effect of weight loss on fetal growth in
terms of the probabilities of low birth weight and SGA
neonates.
The prevalence of macrosomia has been increas-
ing in our region over the past 15 years (Flemish
Study Center for Perinatal Epidemiology, unpub-
lished data) and has consequences for the child at
short and long term.10,24 An estimated optimal gesta-
tional weight gain should be defined in relation to the
lowest predicted risk of both low birth weight, SGA
neonates and macrosomia, LGA neonates, because
all of these risks are related to perinatal morbidity
and mortality.25,26 The study of Beyerlein et al27 sug-
gested an optimal gestational weight gain range for
obese women between 215 and +2 kg for a joint
LGA (Greater Than the
90th Percentile)* (n52,830) Low Birth Weight (n5246)
SGA (Less Than the 10th
Percentile)* (n51,231) Admission to NICU (n5317)
0.60 (0.35–1.05) 0.65 (0.16–2.72) 1.48 (0.93–2.34) 0.59 (0.14–2.44)
0.41 (0.23–0.74) 0.83 (0.25–2.72) 1.35 (0.87–2.08) 1.23 (0.49–3.09)
0.72 (0.59–0.88) 1.30 (0.83–2.03) 1.23 (1.00–1.51) 0.61 (0.36–1.05)
1.00 1.00 1.00 1.00
1.59 (1.41–1.79) 0.68 (0.48–0.96) 0.62 (0.53–0.72) 0.93 (0.69–1.27)
0.41 (0.18–0.96) 2.32 (0.65–8.32) 1.90 (0.97–3.73) 0.43 (0.06–3.19)
0.80 (0.48–1.35) 1.92 (0.62–5.96) 1.50 (0.83–2.68) 0.54 (0.13–2.29)
0.73 (0.54–0.99) 1.03 (0.43–2.48) 1.11 (0.76–1.62) 0.49 (0.21–1.13)
1.00 1.00 1.00 1.00
1.71 (1.39–2.09) 0.92 (0.47–1.80) 0.76 (0.55–1.04) 0.83 (0.49–1.39)
0.21 (0.08–0.54) 1.27 (0.24–6.65) 1.53 (0.65–3.60)
0.60 (0.29–1.23) 0.93 (0.11–7.98) 1.26 (0.46–3.46) 0.20† (0.03–1.53)
0.71 (0.48–1.06) 1.30 (0.41–4.15) 0.97 (0.50–1.88) 0.64 (0.22–1.87)
1.00 1.00 1.00 1.00
1.17 (0.84–1.63) 0.49 (0.14–1.78) 0.73 (0.39–1.36) 1.25 (0.57–2.71)
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predicted risk of 20% or less of either SGA or LGA
births. This range corresponds to our calculated
weight gain for the lowest predicted probability of
SGA and LGA neonates in the three different classes
of obese women.
From a clinical point of view, our data show that
obese women have better perinatal outcomes when
they gain less than currently advised by the IOM, but
this needs confirmation in prospective cohorts. Ideally,
weight loss should be emphasized preconceptionally.
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Fig. 1. Predicted probabilities of maternal and neonatal outcomes by class of obesity. Body mass index (kg/m2) of 30.0–34.9
(A), 35.0–39.9 (B), and 40.0 or higher (C).
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On the other hand, taking part in healthy lifestyle
coaching programs during pregnancy with a focus on
healthy diet and stimulating physical activity can have
benefits for both the mother and child.28,29
The strength in this analysis is the representative-
ness of this large regional cohort of obese pregnant
women at term. We were therefore able to make
a distinction among the various classes of weight
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Fig. 2. Predicted probability of small-for-gestational age and large-for-gestational age neonates by gestational weight gain
and stratified by class of obesity. Body mass index (kg/m2) of 30.0–34.9 (A), 35.0–39.9 (B), and 40.0 or higher (C).
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change during pregnancy, including low weight gain
(0–5 kg), lesser weight loss (between 0 and 5 kg) as
well as greater weight loss (5 kg or greater). A gradual
reduction in gestational hypertension, macrosomia,
and LGA was associated with a decreasing category
of weight change. We controlled for possible con-
founders such as maternal and gestational age and
parity. A limitation in our study is that we did not
control for maternal education, ethnicity, and smok-
ing behavior because these data were not available,
which can also influence some perinatal outcomes.
However, in an earlier study,13 we showed that obese
women are more likely to be less educated, making
them even more vulnerable for caesarean delivery
and lower birth weight of term neonates.12 Our data
did not include information about the reasons for
weight loss (eg, as a result of pregnancy complications
or severe maternal illness or intentional weight loss).
Further studies are underway to study the influence of
weight loss on lean and fat mass in the fetus and neo-
nate.19,30 Our analysis is restricted to full-term single-
ton live births, so these results may not be generalized
to all pregnancies. Cause and effect cannot be deter-
mined by observational studies, so optimal gestational
weight gain must be answered by performing a rigor-
ous randomized controlled trial. A recent randomized
trial of Dodd et al,31 offering healthy eating and exer-
cise advice to pregnant women who were overweight
or obese, showed a significant reduction in the num-
ber of neonates with birth weights greater than 4 kg,
with a number needed to treat of 28. Unfortunately,
they did not reduce the risk of delivering a neonate
weighing above the 90th centile. We are awaiting re-
sults from the UPBEAT32 and DALI33 trials to study
effects of gestational weight gain on maternal and neo-
natal outcomes. When revising the gestational weight
gain guidelines, long-term consequences of gestational
weight gain (eg, chronic diseases such as hyperten-
sion, diabetes, and obesity) should be analyzed in light
of mortality and morbidity.
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